Medication info

Myal Injection (Sodium Hyaluronate)

Prescription medicationInjectionsInjection
Ingredient · strength
Sodium Hyaluronate›10mg / 1mL
Manufacturer / importer
Hawon Pharmaceutical Co., Ltd.
Appearance
A colorless, transparent, and viscous liquid contained in a glass vial (pre-filled syringe) sealed with rubber plugs at both ends.
Packaging
2ml/vial × 3 vials
Approval status
Active

MFDS item code 201309562 · Notified 2013.10.04 · Insurance code 651503471

Summary

Main use
Treatment of periarthritis of the shoulder and knee osteoarthritis
Who receives it
Adults
Adult administration
The usual adult dose is 1 vial once weekly for 3 consecutive weeks, administered into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps). Adjust the number of administrations as appropriate according to symptoms. Because this drug is administered intra-articularly, administer using strict aseptic technique.

Ingredients

Manufacturer
Hawon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of periarthritis of the shoulder and knee osteoarthritis

  • Knee osteoarthritis
  • subacromial bursitis
View approved original text

This medication is used to treat knee osteoarthritis and subacromial bursitis.

How it is given

Adult administration

The usual adult dose is 1 vial once weekly for 3 consecutive weeks, administered into the knee joint or shoulder joint (glenohumeral joint, subacromial bursa, or tendon sheath of the long head of the biceps). Adjust the number of administrations as appropriate according to symptoms. Because this drug is administered intra-articularly, administer using strict aseptic technique.

Precautions

This medication should not be used in patients who have experienced an allergic reaction to any of its ingredients. Caution is required for patients who have a history of allergies to other medications or have liver function issues or liver disease history, as liver function abnormalities may occur. If there are skin diseases or infections at the injection site, caution should be taken since this medication is injected into the joint. Severe allergic reactions, including shock, may occur while using this medication. If symptoms arise, administration should be stopped immediately, and appropriate treatment should be provided. Additionally, hypersensitivity reactions such as swelling of the face, rash, and itching may occur, and administration should be stopped for these symptoms. Temporary pain, swelling, redness, warmth, and a feeling of pressure may occur at the injected joint site. Symptoms such as nausea, vomiting, and fever have also been reported occasionally. If there is severe inflammation in the joint, using this medication may exacerbate the inflammation, so it is recommended to use it after the inflammation has subsided. After administration, caution is needed to stabilize the joint area, and if the medication leaks out of the joint during injection, it may cause pain, so injection should be made accurately into the joint. Injections must be performed under strict aseptic conditions, and if symptoms do not improve, administration should be stopped after 3 doses. If there is a large amount of joint fluid, aspiration may be necessary before injection. This medication should not be administered intravascularly or used for ophthalmic purposes, and appropriate needles should be used. Also, caution should be taken as precipitation may occur when mixed with certain antiseptics. Administration should be done cautiously in women who are pregnant or may become pregnant, and breastfeeding should be avoided during administration. Safety for pediatric use is not established, so it should be used cautiously only when necessary. Elderly patients may have decreased physical function, so administration should be carried out with caution.

Side effects

shock symptoms, swelling (facial, eyelid, etc.), facial flushing, rash, hives, itching, pain (mainly transient pain after administration), swelling, edema, redness, warmth, severe local pressure sensation, nausea, vomiting, fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees Celsius to safely preserve the medication's efficacy.

Appearance and packaging

Appearance

A colorless, transparent, and viscous liquid contained in a glass vial (pre-filled syringe) sealed with rubber plugs at both ends.

Package unit

2ml/vial × 3 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.